Unity’s UBX1325 Faces Uncertain Path Forward In AMD, But DME Still Looks Promising

 
• By Alaric DeArment
  
Unity announced results from its Phase II study in wet AMD • Source: Shutterstock

More from Clinical Trials

More from R&D